Chondrogenix will apply this approach to develop a safe, efficient and scalable source of mature and functional chondrocytes (cartilage cells) to ultimately be used in the clinic to enhance the already approved autologous chondrocyte implantation (ACI) therapy and create additional allogeneic and in vivo reprograming therapies for the treatment of osteoarthritis and other musculoskeletal conditions.